These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19845417)

  • 1. Visual field loss in patients with refractory partial epilepsy treated with vigabatrin: final results from an open-label, observational, multicentre study.
    Wild JM; Chiron C; Ahn H; Baulac M; Bursztyn J; Gandolfo E; Goldberg I; Goñi FJ; Mercier F; Nordmann JP; Safran AB; Schiefer U; Perucca E
    CNS Drugs; 2009 Nov; 23(11):965-82. PubMed ID: 19845417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vigabatrin and epilepsy: lessons learned.
    Wild JM; Ahn HS; Baulac M; Bursztyn J; Chiron C; Gandolfo E; Safran AB; Schiefer U; Perucca E
    Epilepsia; 2007 Jul; 48(7):1318-27. PubMed ID: 17635558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the risk of visual field loss arising from long-term exposure to the antiepileptic drug vigabatrin: a cross-sectional approach.
    Wild JM; Fone DL; Aljarudi S; Lawthom C; Smith PE; Newcombe RG; Lewis GD
    CNS Drugs; 2013 Oct; 27(10):841-9. PubMed ID: 23990316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review.
    Maguire MJ; Hemming K; Wild JM; Hutton JL; Marson AG
    Epilepsia; 2010 Dec; 51(12):2423-31. PubMed ID: 21070215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the topography of absolute defects in patients exposed to the anti-epileptic drug vigabatrin and in normal subjects using automated static suprathreshold perimetry of the entire 80° visual field.
    Besch D; Schiefer U; Eter N; Burth R; Elger CE; Spitznas M; Dietz K
    Graefes Arch Clin Exp Ophthalmol; 2011 Sep; 249(9):1333-43. PubMed ID: 21380539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detecting vigabatrin toxicity by imaging of the retinal nerve fiber layer.
    Wild JM; Robson CR; Jones AL; Cunliffe IA; Smith PE
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):917-24. PubMed ID: 16505024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual fields at school-age in children treated with vigabatrin in infancy.
    Gaily E; Jonsson H; Lappi M
    Epilepsia; 2009 Feb; 50(2):206-16. PubMed ID: 19215279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vigabatrin-induced peripheral visual field defects in patients with refractory partial epilepsy.
    Sergott RC; Bittman RM; Christen EM; Sagar SM
    Epilepsy Res; 2010 Dec; 92(2-3):170-6. PubMed ID: 20951555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal retinal nerve fiber layer attenuation: a biomarker for vigabatrin toxicity.
    Lawthom C; Smith PE; Wild JM
    Ophthalmology; 2009 Mar; 116(3):565-71. PubMed ID: 19168223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective Derivation of the Morphology and Staging of Visual Field Loss Associated with Long-Term Vigabatrin Therapy.
    Wild JM; Smith PEM; Knupp C
    CNS Drugs; 2019 Aug; 33(8):817-829. PubMed ID: 31250314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lack of clinically apparent vision loss among patients treated with vigabatrin with infantile spasms: The UCLA experience.
    Schwarz MD; Li M; Tsao J; Zhou R; Wu YW; Sankar R; Wu JY; Hussain SA
    Epilepsy Behav; 2016 Apr; 57(Pt A):29-33. PubMed ID: 26921595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of visual field loss over ten years in individuals taking vigabatrin.
    Clayton LM; Stern WM; Newman WD; Sander JW; Acheson J; Sisodiya SM
    Epilepsy Res; 2013 Aug; 105(3):262-71. PubMed ID: 23541931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal structure and function in vigabatrin-treated adult patients with refractory complex partial seizures.
    Sergott RC; Johnson CA; Laxer KD; Wechsler RT; Cherny K; Whittle J; Feng G; Lee D; Isojarvi J
    Epilepsia; 2016 Oct; 57(10):1634-1642. PubMed ID: 27580566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of peripapillary retinal nerve fiber layer thinning in vigabatrin-exposed individuals.
    Clayton LM; Devile M; Punte T; de Haan GJ; Sander JW; Acheson JF; Sisodiya SM
    Ophthalmology; 2012 Oct; 119(10):2152-60. PubMed ID: 22853973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Topographical Relationship between Visual Field Loss and Peripapillary Retinal Nerve Fibre Layer Thinning Arising from Long-Term Exposure to Vigabatrin.
    Wild JM; Aljarudi S; Smith PEM; Knupp C
    CNS Drugs; 2019 Feb; 33(2):161-173. PubMed ID: 30637668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal nerve fibre layer attenuation: clinical indicator for vigabatrin toxicity.
    Moseng L; Sæter M; Mørch-Johnsen GH; Hoff JM; Gajda A; Brodtkorb E; Midelfart A
    Acta Ophthalmol; 2011 Aug; 89(5):452-8. PubMed ID: 21251242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vigabatrin and visual field defects. A Danish material with evaluation of different screening methods].
    Riise P; Fledelius HC; Rogvi-Hansen Bà
    Ugeskr Laeger; 2003 Mar; 165(10):1034-8. PubMed ID: 12645411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vigabatrin-associated loss of vision: rarebit perimetry illuminates the dose-damage relationship.
    Frisén L
    Acta Ophthalmol Scand; 2004 Feb; 82(1):54-8. PubMed ID: 14738486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication.
    Hardus P; Verduin WM; Postma G; Stilma JS; Berendschot TT; van Veelen CW
    Epilepsia; 2000 May; 41(5):581-7. PubMed ID: 10802764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal.
    Newman WD; Tocher K; Acheson JF
    Eye (Lond); 2002 Sep; 16(5):567-71. PubMed ID: 12194070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.